Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jul 11.
Published in final edited form as: J Am Chem Soc. 2012 Jun 28;134(27):11206–11215. doi: 10.1021/ja303168n

Carboxylation and Decarboxylation of Active Site Lys 84 Controls the Activity of OXA-24 β-Lactamase of Acinetobacter baumannii: Raman Crystallographic and Solution Evidence

Tao Che 1, Robert A Bonomo 3,6, Sivaprakash Shanmugam 1, Christopher R Bethel 3, Marianne Pusztai-Carey 1, John D Buynak 2,*, Paul R Carey 1,*
PMCID: PMC3404726  NIHMSID: NIHMS389798  PMID: 22702961

Abstract

The class D β-lactamases are characterized by the presence of a carboxylated lysine in the active site that participates in catalysis. Found in Acinetobacter baumannii, OXA-24 is a class D carbapenem hydrolyzing enzyme that exhibits resistance to most available β-lactamase inhibitors. In this study, the reaction between a 6-alkylidiene penam sulfone inhibitor, SA-1-204, in single crystals of OXA-24 is followed by Raman microscopy. Details of its reaction with SA-1-204 provide insight into the enzyme’s mode of action and help define the mechanism of inhibition. When the crystal is maintained in HEPES buffer, the reaction is fast, shorter than the time scale of the Raman experiment. However, when the crystal holding solution contains 28% PEG 2000, the reaction is slower and can be recorded by Raman microscopy in real time; the inhibitor’s Raman bands quickly disappear, transient features are seen due to an early intermediate, and, at approximately 2 to 11 minutes, new bands appear that are assigned to the late intermediate species. At about 50 minutes, bands due to all intermediates are replaced by Raman signals of the unreacted inhibitor. The new population remains unchanged indicating i) that the OXA-24 is no longer active and ii) that the decarboxylation of Lys84 occurred during the first reaction cycle. Using absorbance spectroscopy, a one cycle reaction could be carried out in aqueous solution producing inactive OXA-24 as assayed by the chromogenic substrate nitrocefin. However, activity could be restored by reacting aqueous OXA-24 with a large excess of NaHCO3 which recarboxylates Lys84. In contrast the addition of NaHCO3 was not successful in reactivating OXA-24 in the crystalline state; this is ascribed to the inability to create a concentration of NaHCO3 in large excess over the OXA-24 that is present in the crystal. The finding that inhibitor compounds can inactivate a class D enzyme by promoting decarboxylation of an active site lysine suggests a novel function that could be exploited in inhibitor design.

INTRODUCTION

Class D β-lactamases, also known as oxacillinases or OXA enzymes, due to their enhanced capability to hydrolyze oxacillin, can possess carbapenemase or extended-spectrum cephalosporinase activity,1-3 and are important determinants of antimicrobial resistance in Gram-negative pathogens, particularly including Acinetobacter baumannii and Pseudomonas aeruginosa.4-7 Both A. baumannii and P. aeruginosa represent two of the most difficult pathogens to treat as they are often multidrug resistant (MDR) and pose a significant threat to hospitalized patients.8 Class D enzymes are frequently not inhibited by the commercial β-lactamase inhibitors, clavulanic acid, sulbactam, and tazobactam. Unlike class A and C serine β-lactamases, the class D β-lactamases have a characteristic hydrolytic mechanism involving a carboxylated lysine residue, which is believed to function as the catalytic base, both during initial acylation of the active site serine and during hydrolysis of the intermediate acyl-enzyme, as shown in Scheme 1.9,10 While there are examples of carboxylated lysine residues in other enzymes,11,12 it is unusual for this residue to have a direct mechanistic role. One exception to this rule is the antibiotic sensor domain of the BlaR1 protein of the Gram-positive Staphylococcus aureus, which shares 28% sequence identity and high backbone homology with class D β-lactamases.10,13 Rather than catalyzing the hydrolysis of penicillin like the class D β-lactamases, the BlaR1 sensor forms a stable acyl-enzyme with penicillins, leading to a conformational change in the protein; this relays a signal to the cytoplasm that derepresses the transcription of β-lactamase.13-16

Scheme 1.

Scheme 1

The reaction pathway for penicillin hydrolyzed by OXA-24 β-lactamase.19

The carboxylated lysine residue of the class D β-lactamases and the BlaR1 sensor are proposed to be crucial with respect to their differing behavior in the presence of β-lactams.10,13 As noted by numerous investigators, the carboxy terminus of this residue is positioned analogously to E166 of the class A β-lactamases, and properly positioned to function as the catalytic base for both acylation and deacylation in class D β-lactamases. Lysine of the BlaR1 sensor undergoes decarboxylation subsequent to formation of the acyl-enzyme, thus removing the requisite base from the vicinity of the acylated serine, and leading to a stable acyl-enzyme,13,15 while in some cases the β-lactamases are able to retain the carboxy group and complete the hydrolytic cycle.

Structural and mechanistic features which promote the formation and stabilization of carboxylysine residues are poorly understood. Therefore, discerning the factors that allow class D β-lactamases to form and maintain a carboxylated lysine, while promoting decarboxylation of the analogous residue in BlaR1 could provide insight leading to design of more effective β-lactamase inhibitors.

In order to understand its chemical properties and potential decarboxylation pathways, a carboxylated lysine can be compared with the hypothetical carbamic acid (H2NCO2H). Carbamic acid is predicted to have a pKa of 5.89 (COOH) and −1.22 (protonation of the nitrogen), (Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2012 ACD/Labs), thus verifying the protonation occurs on the oxygen of the more basic, and properly positioned, carboxylate anion, and posing the mechanistic issue of how subsequent decarboxylation (and consequent transfer of the proton from oxygen to nitrogen) may occur. Calculations on the decarboxylation of the carbamic acid molecule indicate that the activation energy can be lowered by 44 kcal/mole by the assistance of one water molecule, as shown in Scheme 2.17,18 Direct transfer of the proton from the (carboxy group) oxygen to the nitrogen, with appropriate geometry for the proton to interact with the nitrogen electron pair, while simultaneously maintaining the amide bond resonance, would involve a four-membered transition state and proton transfer over a distance of approximately 2.72 Å, as shown in Scheme 2A. The N-HO distance is reduced to 2.29 Å by rotating about the amide CO-N bond to the high energy conformation (Scheme 2B). By contrast, incorporating assistance from a neighboring water molecule, which could simultaneously provide H-bond donor and acceptor interactions with the carboxylated lysine would involve a six-membered transition state and achieves optimal bond distances from the low energy amide conformation as shown in Scheme 2C. Bou et al.19 recently proposed that the reason for the divergent behavior of class D β-lactamases and BlaR1 is the presence of a suitable water molecule to facilitate loss of CO2 in BlaR120 and the absence of a corresponding water in the case of the β-lactamases, a difference potentially caused by the positioning of a highly conserved 1 hydrophobic valine (or isoleucine) residue at the β-lactamase position 130 (DBL consensus numbering) and a hydrophilic asparagine residue at corresponding position 109 in BlaR1 as illustrated in Fig. 1.21

Scheme 2.

Scheme 2

The addition of one water molecule lowers the activation energy during the decarboxylation process of carbamic acid.

Figure 1.

Figure 1

Comparison of the active-site carboxylysine environment of OXA-24 β-lactamase (PDB entry 3G4P) with BlaR1 sensor (PDB entry 1XA1).

In this paper we use Raman spectroscopy to explore the details of the reaction of OXA-242 with a 6-alkylidiene penam sulfone inhibitor, SA-1-204 (Box-1). This analysis provides novel insight into the enzyme’s mode of action and shows that (de)carboxylation of Lys84 acts as a catalytic switch.13 Earlier work concluded the reaction between SA-1-204 and OXA-1 or SHV-1 (a class A β-lactamase) in a single crystal occurs slowly in HEPES buffer, forming a non-covalent Michaelis-like complex that is stable in the active site up to one hour before hydrolysis.22 However, new evidence we obtained for SHV-1 (Shanmugam and Carey, unpublished work) shows that the reaction is actually fast in HEPES buffer and is complete in less than 3 minutes. For SHV-1, the reaction can be slowed by the addition of PEG 6000, which allows us to record the reaction including intermediate species using Raman microscopy, which is also the case as shown here for OXA-24. Likely that the reaction is also fast in OXA-1 in the absence of PEG, but slow in the presence.

MATERIALS AND METHODS

Inhibitors

SA-1-204 was synthesized as described previously.23 A stock solution of the inhibitor at 20 mM in 10 mM HEPES buffer (pH 7.5) was prepared for “soak in” experiments with the protein crystals and for UV-absorbance studies. Potency was verified using the colorimetric β-lactamase substrate nitrocefin (Becton Dickson, λ max= 482 nm; ε= 17400 M−1cm−1) .

Protein Isolation, Purification, and Crystallization

E. coli BL21 (DE3) cells including pET24 (+) plasmid vector containing blaOXA-24 have been described previously.19 These cells were grown in super optimal broth (SOB) containing 50 μg/ml kanamycin at 37 °C in shaker flasks to achieve an OD600 around 0.6-0.8. Then IPTG (isopropyl β-D-1-thiogalactopyranoside) was added to the culture with a final concentration of 0.2 mM and the culture was grown for three more hours. The cells were spun down by centrifugation and frozen at −20 °C. The cultures were warmed back to room temperature and lysed by adding lysozyme and sonicating. The supernatant was collected for further purification. OXA-24 β-lactamase was purified by combination of gel filtration and ion exchange chromatography. A gel filtration HPLC (high pressure liquid chromatography) purification step was performed using a Sephadex Hi Load 26/60 column (GE Healthcare) and elution with 50 mM sodium phosphate buffer (pH 7.4). Ion exchange chromatography was performed using Q sepharose and elution with a NH4HCO3 gradient. Concentration of the protein was measured by Bio-Rad’s protein assay, and the purity of the enzyme was evaluated by SDS-PAGE. Following purification, the OXA-24 β-lactamases were crystallized using the protocol of Bou et al.19 Briefly, OXA-24 was concentrated to 6 mg/ml in 10 mM HEPES buffer (pH 7.5). Crystals were grown by the hanging drop vapor diffusion method in a crystallization solution containing 0.1 M HEPES (pH 7.5), 0.1M sodium acetate and 28% PEG 2000. The crystals were obtained in 4-6 days with the dimensions of 0.12 × 0.12 × 0.08 mm.

Raman Crystallography

The Raman microscope system has been described previously.24,25 A single OXA-24 crystal was transferred from the mother liquor solution to a 4 μL drop of 0.1 M HEPES (pH 7.5), 0.1 M NaOAc and 28% PEG 2000. A 647 nm, 80 mW Kr+ laser beam (Innova 70 C, Coherent, Palo Alto, CA) was focused on the protein crystals in the 4 L hanging drop using the 20× objective of the Raman microscope. During data collection, spectra were acquired for 10 s and 10 accumulations were averaged for each time point. The spectrum of inhibitor SA-1-204 was first taken in the absence or presence of PEG. After obtaining spectra of the apo OXA-24 protein crystals, inhibitors were soaked into the drop to achieve a final volume of 5 L and a final inhibitor concentration of 5 mM. Spectra were then acquired every 2-3 min after addition of the inhibitors. To obtain difference spectra, an apo β-lactamase spectrum was subtracted from the protein-inhibitor spectra at varying time intervals following addition of inhibitor (Supplemental Text 1).

Ramandifferencespectrum=[protein+inhibitor][protein]

Absorbance Studies

For the NaHCO3 reactivating experiment in a 500 μL reaction system with or without 28% PEG, OXA-24 was mixed with SA-1-204 in the presence or absence of NaHCO3. Nitrocefin was used as a chromogenic substrate for OXA-24. The final concentrations were OXA-24 5 μM, SA-1-204 50 μM, nitrocefin 20 μM, NaHCO3 100 μM or 100 mM. UV-visible absorbance spectra were taken. Each spectrum included absorbance at wavelengths (λ) from 200 nm to 600 nm. These spectra were recorded at 30 second intervals, with the length of the experiment 30 min. The spectra were saved as individual files grouped by experiment and the spectra shown in Figure 4 are the average of these.

Figure 4.

Figure 4

Recarboxylation of the lysine residue 84 in the active site can restore the OXA-24 hydrolytic activity towards nitrocefin. Black line: OXA-24 was 5 μM in HEPES buffer(10 mM, pH 7.5), then 20 μM NCF was added and the UV-absorbance spectrum was recorded; Red line: reagents were added in the order of 5 μM OXA-24, 50 μM SA-1-204, 20 μM NCF at the intervals of 1min, then the UV-absorbance spectrum was recorded; Green line: reagents were added in the order of OXA-24, SA-1-204, NCF, 6and 100 μM sodium bicarbonate, then UV-absorbance spectrum were recorded every 30 seconds in the next 30 minutes; Blue line: the same as in the Green line except that the sodium bicarbonate concentration was 100 mM; Cyan line: the same as in the Green line except using 100 mM sodium bisulfate.

Calculations

Ab initio quantum mechanical calculations were performed on CWRU’s cluster facility to predict the Raman spectra of SA-1-204 and model intermediate compounds using Gaussian 03.26 Calculations were performed at the DFT5 level using the 6-31+G(d) basis set. DFT calculations were performed with Becke’s three parameter hybrid method using the correlation functional of Lee, Yang, and Parr (B3LYP). The vibrations giving rise to the most intense calculated peaks could be visualized using “GaussView”, revealing which molecular vibrations contribute to the peaks.

RESULTS AND DISCUSSION

a) The presence of PEG can decelerate the OXA-24 β-lactamase reaction with SA-1-204 inhibitor

Previous studies in our lab indicated that the reaction between SA-1-204 (Box-1) and OXA-1 in single crystal is slow, with little change occurring in the spectrum of the bound ligand in one hour.22 However, crystallographic studies of several other 6-alkylidene-2′-substituted sulfones, with similar structures to the SA-1-204, reacting with OXA-24 in single crystals show that a quasi-stable bicyclic aromatic late intermediate (Z in Scheme 3) forms after 6 minute soaks in the presence of PEG 2000.19

Scheme 3.

Scheme 3

Proposed mechanism of OXA-24 β-lactamase inhibition by SA-1-204. In SA-1-204, R1 is - O(C=O)CH2Ph (modified from Bou et al., 2010).19

In order to compare the reaction in the presence or absence of PEG, we use Raman microscopy to study the reaction in single crystals in real time. At first sight, the data in Fig. 2A, the time dependence of SA-1-204 reacting in an OXA-24 crystal in HEPES-based holding solution, suggest that no reaction has occurred from 2 minutes to 50 minutes. However, close examination shows that weak peaks occur at 2 minutes like 1440 cm−1 and 1322 cm−1 and then decrease with time. These peaks are assigned to late intermediate species Z in Scheme 3 in section b) below. Essentially, we these data suggest that one reaction cycle is complete at 2 minutes (the experimental “dead time” of our Raman approach) leaving a trace of late intermediate which is slowly hydrolyzed with time. At 2 minutes, most active sites are reoccupied by new SA-1-204 but this second molecule of substrate does not react since , as elucidated below, the active site is no longer functional. However, the situation is dramatically different when PEG is added to the holding solution. Fig. 2B shows the time dependent Raman difference spectrum for the inhibitor SA-1-204 reacting in single crystals of OXA-24 in mother liquor containing 28% PEG 2000. The results show that the reaction now occurs more slowly (Fig. 2B). In the figure, at 2 minutes, the substrate peaks have almost disappeared and new peaks appear. In the presence of PEG, we can see not only the late intermediate peaks like 1443 cm−1, 1339 cm−1 and 1322 cm−1 (assigned below) but also peaks like 1657 cm−1 that decay rapidly and are assigned to an early intermediate X in Scheme 3 (Section b) below). This indicates that, at 2 minutes, the reaction is still proceeding whereas we saw, in the absence of PEG, that the first cycle of the reaction was complete at 2 minutes.

Figure 2.

Figure 2

Raman difference spectra of OXA-24 single crystal reaction with SA-1-204 in the absence or presence of PEG 2000. A. Raman difference spectrum of OXA-24 and SA-1-204 at 2 min, 11 min, 18 min, 50 min in the absence of PEG. Control spectrum of unreacted SA-1-204 was first taken in the absence of PEG. After SA-1-204 was soaked in, the spectra were taken at above indicated time points. The reaction is almost complete at 2 min. B. Raman difference spectrum of OXA-24 and SA-1-204 at 2 min, 11 min, 18 min, 50 min in the presence of PEG. Control spectrum of SA-1-204 was first recorded in the presence of PEG. After SA-1-204 was soaked in, the spectra were taken at above indicated time points. The presence of PEG decelerates the OXA-24 β-lactamase reaction with SA-1-204 inhibitor.

The findings for the reaction in single crystals above also find support from the experiment undertaken in solution. We used nitrocefin to monitor the enzyme activity in solution in the presence or absence of PEG 2000 since nitrocefin produces an intense red chromophore in the presence of active β-lactamase. After 50 μM SA-1-204 was incubated with 5 μM OXA-24 in the absence of PEG, the enzyme activity was tested every minute. The result showed that the enzyme was completely inhibited at 1 minute since the nitrocefin was not hydrolyzed and the red chromphore did not appear.27 However, in the presence of PEG, the enzyme was still reactive after 5 minutes since nitrocefin was hydrolyzed and product was formed.27 The enzyme was not completely inhibited until 10 minutes in the presence of PEG because acylation is slowed and active OXA-24 is present until about 10 minutes. In toto, the results indicate that in crystallo or in solution reaction is occurring quickly in HEPES-based solutions but is slowed markedly in solutions containing PEG.

Possible explanations for why 20-30% PEG can decrease the reaction velocity is that PEG may either slow down the molecular diffusivity or necessary conformational changes in the active site due to increasing the viscosity of the solution. The viscosity generally increase when the concentration or the average weight of PEG increases.28 Earlier work showed that PEG acts as a macroviscogen that can help increase the macroscopic viscosity of solution without slowing down the rate of diffusion of small molecules in the solution.29 Thus, in our experiment, the viscosity (η) of solution in the presence of 28% PEG 2000 in crystallo is estimated to be about 9.781 mPas which is nine times the viscosity of water (η = 1.0045 mPas).28 The increase in viscosity of the solution due to the presence of PEG decelerates the reaction by slowing down the conformational changes needed in the active site to form intermediates and products. The slower reaction in the presence of PEG allows us to visualize the progression of the reaction in crystallo in real time by use of Raman microscopy.

b)The reaction of SA-1-204 in OXA-24 crystals undergoes only one cycle

In the previous section, we propose that SA-1-204 reacts much faster in OXA-24 crystals surrounded by holding solution that does not contain PEG 2000. Under both sets of conditions with or without PEG, the OXA-24 / SA-1-204 reaction goes through just one cycle resembling the reaction in Scheme 3. We now provide evidence to support this claim. First, we examine the kinetic data for the peaks occurring in the slower reaction in the presence of PEG (Fig. 2B). This helps us assign the non-substrate peaks in Fig. 2B to special features from postulated intermediate seen in Scheme 3. In turn this allows us to identify peaks in the fast and slow reactions (Figs. 2A and 2B) and show that it is likely that only one reaction cycle has occurred.

In the reaction of SA-1-204 in OXA-24 single crystal in the presence of 28% PEG 2000, the results show that the reaction occurs relatively slowly and appears to go through only one cycle (Fig. 2B). In the figure, at 2 minutes, the substrate peaks have almost disappeared and new peaks appear. The peak at 1695 cm−1 in the spectrum is assigned to the methylenic double bond stretch coupled to the pyridine mode which is expected to change markedly when the β-lactam ring opens and the hybridization at C6 changes (see below). Another characteristic feature is at 1761 cm−1, which originates from the carbonyl (C=O) group of the intact lactam ring (see below). In previous reports of reactions between β-lactamases and inhibitors sulbactam, tazobactam and clavulanic acid, the disappearance of this peak is ascribed to opening of the lactam ring and acylation of the enzyme.30 In the present experiment, the peaks at 1761 and 1695 cm−1 disappear, showing that the reaction is occurring. The peak at 1000 cm−1 corresponds to the phenyl ring mode in SA-1-204 structure which acts as an “internal standard” to monitor the reaction since it remains unchanged during the reaction (see below). At about 11 minutes (Fig. 2B), the substrate peak at 1695 cm−1 begins to regain intensity probably as a result of product leaving the active site and the substrate reentering. After 11 minutes, the substrate peaks continue to “grow in” reaching a maximum at 50 minutes. Surprisingly the substrate remains in the active site unchanged and does not appear to undergo catalysis.

Based on the structures of substrates similar to SA-1-204 and the constitution of the active site in OXA-24, the mechanism proposed by Bou et al.19 is taken as a working model as shown in Scheme 3. To identify whether the proposed mechanism is consistent with the observed Raman spectra, ab initio quantum mechanical calculations were used to predict the Raman spectra for some of the species seen in Scheme 3. Using the Gaussian program,26 calculations were performed for the free substrate, the early intermediate X and the late intermediate Z (Scheme 3) since x-ray crystallographic data support their existence. For free substrate SA-1-204 (Table 1), the peaks at 1761 cm−1 and 1695 cm−1 (Fig. 2B) have been described above (yellow and red regions, respectively in the cartoon), as well as the peak at 1000 cm−1 (green region). Based on the Gaussian calculations, the other narrow features at 1588 cm−1 and 1570 cm−1 (Figs. 2A and 2B) have contributions from the -SO2- group and pyridine group motions (purple and orange regions, respectively in the cartoon). The 1472 cm−1 feature is due to a pyridine mode (orange region) while the 1216 cm−1 mode is from methylenic stretch coupled to the pyridine modes (red region).

Table 1. Peak assignment for unreacted SA-1-204 from Gaussian calculations.

graphic file with name nihms-389798-t0010.jpg

Calculation results of unreacted SA-1-204
Experimental group
(cm−1)
Calculated group
(cm−1)
Raman intensity
(calculated)
Peak assignment
1760 1745 128
1695 1694 2335
1588 1625 150
1570 1625 88
1472 1458 173
1216 1252 197
1000 998 30

For the proposed intermediate X (Scheme 3 and Table 2), the intense peak at 1658 cm−1 (Fig. 2B) is assigned to an in-plane mode involving pyridine and the skeleton to N4 (red region). The 1447 cm−1 peak derives from the ester group covalently linked to the enzyme (blue region). There are two intense vibrations predicted by the calculation that may be unresolved in the experimental 1658 cm−1 feature (Fig. 2B). Amide I features from α-helices also appear near 1658 cm−1.31 However, it is unlikely that the 1658 band is due to changes in α-helices. These invariably give rise to a feature near 945 cm−1 32-34 and there is no evidence for a time dependent feature near 945 cm−1 in Fig. 2. In addition, The assignment of the 1658 cm−1 to the protonated imine of intermediate X is further supported by calculations in the imine species in SHV-1 β-lactamase intermediates, this has a calculated and experimental band at 1658 cm−1 that is assigned to C=NH+ stretch.35 They are associated with the red region in Table 2 and strongly support the existence of the intermediate X. On the other hand, the energy-minimized structure of intermediate X derived from the Gaussian calculation (Supplemental Fig. 4) closely resembles the product structures for four related compounds in the active site of OXA-24.19 Thus, it is likely that intermediate X fits within the active site as shown in Figure 2 of Bou et al.19 In particular, they showed that the group at the C2 position of LN-1-255, which only differs from SA-1-204 by two -OH groups in the phenyl ring, fits into the structure of the product complex without steric hindrance around the C2 position. Thus, for SA-1-204, the reaction intermediate X can be formed with little or no steric hindrance.

Table 2. Peak assignment for proposed early intermediate X from Gaussian calculations.

graphic file with name nihms-389798-t0011.jpg

Calculation results of early intermediate X
Experimental group
(cm−1)
Calculated group
(cm−1)
Raman intensity
(calculated)
Peak assignment
1658 1658 859
1640 271
1447 1458 103
1000 998 42

For the late intermediate Z (Scheme 3 and Table 3) that has also been captured by x-ray studies,19 the peaks at 1550, 1339 and 1322 cm−1 are assigned to modes of the doubly-fused rings (red region). The 1447 cm−1 peak is assigned to the ester group and the 1127 cm−1 peak is localized to the five-membered ring (yellow region). The indolizine double ring moiety gives the most intense Raman signal in the calculation of species Z, consistent with the experimental spectra. However, overall this mode is less intense than the 1658 cm−1 band in species X.

Table 3. Peak assignment for proposed late intermediate Z from Gaussian calculations.

graphic file with name nihms-389798-t0012.jpg

Calculation results of late intermediate Z
Experimental group
(cm−1)
Calculation group
(cm−1)
Raman intensity
(calculated)
Peak assignment
1550 1552 173
1447 1424 62
1339 1370 123
1322 1355 61
1127 1092 37
1000 1000 30

Since the peak at 1000 cm−1 is unchanged during the reaction, Ipeak/I1000 can reflect the intensity change of other peaks in real time. Fig. 3 plots the relative intensity of key peaks in the Raman spectra in Fig. 2B as a function of time. The intensity of the substrate peak at 1695 cm−1 decreases quickly as SA-1-204 is soaked in. The peak at 1658 cm−1 increases and decreases faster than other major peaks, indicating it originates from an early intermediate in the reaction. The late intermediate peak at 1322 cm−1 increases and plateaus between 2 minutes and 18 minutes, then declines from 18 minutes to 50 minutes, which indicates the formation of final product that leaves the active site after slowly deacylating. The substrate population declines rapidly over 2 minutes but then increases until at 50 minutes when there appears to be a stable population in the active site. A more extensive set of Raman difference spectra of OXA-24 reaction with SA-1-204 are shown in Supplemental Fig. 1, as well as a more detailed kinetic depiction of intensity changes of the main peaks (Supplemental Fig. 2). From the overall kinetic mechanism, a detailed examination reveals that the reaction follows a very clear order: substrate disappears, intermediate(s) form and leave as the product, substrate reenters without being catalyzed.

Figure 3.

Figure 3

Kinetic depiction of the substrate peak 1695 cm−1 , early intermediate peak 1658 cm−1 and late intermediate peak 1322 cm−1 intensities over time.

Unexpectedly, we find that under the conditions of our reaction in the OXA-24 crystal, the reaction goes through one cycle. This finding is without precedent. Bou et al.19 point out that in contrast to class A β-lactamase, a hydrolytic water molecule is absent in OXA-24 crystallographic structure, and instead, the key role is played by a carboxylated Lys84;36 this Lys84 is of central importance in OXA-24 and essential for catalytic activity.19 In earlier work Golemi et al.9 also shows that at low pH, decarboxylation of the Lys70 (a structurally and mechanistically equivalent residue) leads to the inactivity of the enzyme OXA-10.When the enzyme OXA-10 is regenerated by exposure to bicarbonate, activity is restored and the degree of carboxylation correlates with the degree of recovery of activity.37 Here we propose that the “one cycle” of the reaction is due to the decarboxylation of Lys84 in the active site after the first reaction cycle and that in the crystal environment recarboxylation does not occur (Scheme 3). Support for a one cycle reaction leading to the an inactive enzyme is found in the solution studies described in section c).

c) Recarboxylation of the lysine residue 84 in the active site restores OXA-24’s hydrolytic activity towards nitrocefin in solution

The results discussed above indicate that OXA-24 in the crystal undergoes one catalytic cycle and then becomes inactive. A possible explanation lies in the role of carboxylated lysine 84 residue in the catalytic process. All class D β-lacatamases characterized to date have a carboxylated lysine residue in the active site.9,38-40 In OXA-10 class D β-lactamase, carboxylation is a reversible process.9 The lysine spontaneously decarboxylates at low pH 4.5 but can be recarboxylated by exposure to 20 mM NaHCO3 at pH 7.5. Golemi et al.9 also show that the hydrolysis of most substrates by OXA-10 is characterized by biphasic kinetics due to the presence of an equilibrium between the uncarboxylated and carboxylated forms of Lys70 (see above).37 OXA-24 class D β-lactamase also has a carboxylated Lys84 in its active site.36 Thus, we undertook experiments in solution and in single crystals to test our hypothesis that, in the presence of SA-1-204, Lys84 in OXA-24 becomes decarboxylated during the first cycle of catalysis rendering the enzyme inactive.

In solution, 5 μM OXA-24 was reacted with 20 μM nitrocefin. Nitrocefin was used as a chromogenic substrate to monitor the enzyme activity in solution. Almost all the nitrocefin is transformed into product as evidence in the 482 nm absorbance in Fig. 4 (black line). Next, 5 μM OXA-24 and 50 μM SA-1-204 were mixed first for 1 minute and then 20 μM nitrocefin was added. This gives rise to the absorbance peak near 380 nm in Fig. 4 (red line). A nitrocefin product peak is not visible near 482 nm indicating that SA-1-204 completely blocks the activity of OXA-24 towards nitrocefin. However, when the solution of inhibited OXA-24 (with SA-1-204 and nitrocefin) is treated with 100 μM or 100 mM sodium bicarbonate (NaHCO3), activity is restored and nitrocefin product appears (green and blue lines, respectively). In a control, there was no effect when 100 mM NaHSO4 replaced NaHCO3 (cyan line). ). The same experiment was also repeated in the presence of 28% PEG 2000. Not only could bicarbonate reactivate the OXA-24 enzyme but also PEG could slow down both the decarboxylation and recarboxylation process (data not shown). In addition, UV-absorbance assays show that the reaction between SA-1-204 and OXA-24 is strictly stoichiometric. While 20 μM OXA-24 and 60 μM SA-1-204 are reacted, the spectrum shows only one third of the SA-1-204 (equivalent to the concentration of OXA-24 ) is hydrolyzed, indicating that the reaction undergoes only one cycle under these conditions (Supplemental Fig. 3A). But in the presence of NaHCO3, the enzyme continues hydrolyzing SA-1-204 until the latter is exhausted (Supplemental Fig. 3B). This suggests that the enzyme becomes decarboxylated after the first reaction cycle but can be reactivated by the addition of carbon dioxide generated from bicarbonate.

To probe the reaction in a single crystal, a OXA-24 single crystal (Fig. 5A) is transferred into a fresh hanging drop made up of 0.1 M HEPES (pH 7.5). The concentration of active sites is calculated as 15 mM (Supplemental text). Nitrocefin is injected into the drop to give a final concentration of 1 mM. Nitrocefin is hydrolyzed quickly within the crystal since the crystal turns red immediately (Fig. 5B). When 5 mM SA-1-204 is first soaked into the drop containing a OXA-24 single crystal, no nitrocefin product is generated and the crystal remains yellow (Fig. 5C). When the mixture of above OXA-24 single crystal, SA-1-204 and unreacted nitrocefin is treated with 100 mM NaHCO3, nitrocefin product is still not formed and crystal does not turn red (Fig. 5D), indicating that enzyme remains inactive. Thus, while the “in solution” data the one cycle reaction is a consequence of the lysine decarboxylation that can be rescued by the addition of NaHCO3, activity could not be restored in single crystal. An explanation is that there is an equilibrium between the uncarboxylated and carboxylated Lys84. In the single crystal reaction, the concentration ratio between NaHCO3 and decarboxylated Lys84 is about 7:1 since the protein concentration is about 15 mM (Supplemental Text 2),41 much lower than that in solution 1000 : 1, so that the Lys84 remains non-carboxylated and cannot hydrolyze the next coming nitrocefin.

Figure 5.

Figure 5

Low ratio of concentration between NaHCO3 and OXA-24 (CNaHCO3: COXA-24) is unable to reactivate the enzyme. Single OXA-24 crystal was transferred from the mother liquor solution to a 4 μL drop of 0.1 M HEPES (pH 7.5), 0.1 M NaAc and 28% PEG 2000. SA-1-204, nitrocefin and NaHCO3 were added to test the hydrolysis activity of the crystal. A. OXA-24 crystal in the mother liquor solution. B. 1 μL nitrocefin (1 mg/mL) was added into the solution containing the single OXA-24 crystal. C. 1 μL SA-1-204 (20 mM) was soaked in the single crystal solution for 1 min, then nitrocefin was added. D. 1 μL NaHCO3 (100 mM) was added into the solution after the SA-1-204 and nitrocefin mixture.

Experimental evidence to date has established that the carboxylated lysine residue results from a reaction between the non-protonated ε-amino group of the lysine and carbon dioxide.17 Studies on OXA-10 reveals that Val117, Phe120 and Trp154 in the active site maintain a hydrophobic environment (hydrophobic pocket) for the Lys70, which decreases the pKa of Lys70, favoring its reaction with carbon dioxide.39,42 Crystallographic studies on the active site of OXA-24 indicate that Lys84 is also in a hydrophobic environment, which consists of Val130 and Trp167. Specifically, the residue Trp167 interacts with the carboxylate group of Lys84 and help it locate in an “optimum orientation”. This will also lead to the decrease the pKa of Lys84, which yields a major proportion of non-protonated ε-amino at physiological pH, favoring its carboxylation.9,42,43 The in vivo concentration of CO2 has been reported at 1.3 mM;44 Golemi et al. 9 reported that the dissociation constant (Kd) for CO2 and monomeric OXA-10 β-lactamase was 12.4 ± 0.01 μM. Considering that OXA-24 β-lactamase is also a monomer, this enzyme is expected to be fully carboxylated in its native state.

Regarding the decarboxylative mechanism, loss of CO2 directly from the negatively charged conjugate base of the carbamic acid would involve formation of a nitrogen anion. Given the high pKa (ca.35) of such an unstabilized nitrogen anion, it is logical that decarboxylation of the carbamic acid occurs with concurrent transfer of a proton from oxygen to nitrogen possibly through an intermediate water molecule, predicted theoretically and shown in Scheme 2. This is consistent with the observation that decarboxylation of the lysine also occurs at pH < 4.5. Thus, for continued β-lactam hydrolysis and avoidance of decarboxylation of the carboxylated lysine, it is important for the enzyme to maintain the anionic conjugate base state of the carbamic acid moiety. In the normal hydrolytic sequence, each time the N-carboxy group abstracts a proton, it is rapidly removed, firstly ferrying a proton from the active site serine to the departing N4 as shown in Scheme 1, B to C, (in order to assist departure of that nitrogen from the tetrahedral intermediate and prevent it from assuming a formal negative charge) and secondly from the hydrolytic water to the same nitrogen, this time the nitrogen acting as a simple amine base (pKa 10-11), but nonetheless leaving the carbamic acid as its conjugate base to resume the catalytic cycle (Scheme 1, E to F). With the pyridylalkylidene inhibitor, however, two events interfere with this course of events: 1) the fragmentation of the dioxothiazoline ring system, with ejection of the sulfinate anion, and concomitant intramolecular capture of the resultant imine by the pyridine nitrogen, has now created a positively charged pyridinium ion in Y (Scheme 3), which can form an aromatic indolizine system by loss of a proton from C5 (penam numbering) to the conjugate base of the carbamic acid and placing it in a (conjugate acid) state more susceptible to decarboxylation (Scheme 3, Y to Z); 2) In the subsequently formed aromatic intermediate Z, the (penam) N4 atom is now part of a β-aminoacrylate moiety, and thus has reduced pKa (ca. 5), now insufficient to deprotonate the carbamic acid (pKa = 6), and thus rendering the carboxylysine susceptible to decarboxylation. Once this decarboxylation occurs, the resultant amine of the lysine is too distant from the ester linkage of the acyl-enzyme to efficiently function as a base during the hydrolytic process. Even if the ester is slowly hydrolyzed, without a basic (thiazolidine) nitrogen to carry away the proton from the site, the lysine is left protonated, and unable to react with CO2 in a carboxylative process or to function as a catalytic base to initiate acylation.

In the case of the class A β-lactamases, the hydrolytic water molecule is well ordered and observed crystallographically. By contrast, an active-site water molecule has never been observed for any class D β-lactamase.40 Since water is required for hydrolysis of the acyl-enzyme, it is logical to propose that the hydrolytic water molecule is more disordered in class D, as they have large and more hydrophobic active sites.

Bou et al. had earlier proposed that 6-alkylidenepenicillin sulfone inhibitors, which rearrange to bulky, conformationally rigid indolizines subsequent to acylation of the active site serine, may function by displacing the hydrolytic water.19 The present work seems to imply that, although water is displaced from a position in which it could hydrolyze the acyl-enzyme, water is still present proximal to the carboxylated lysine and is capable of facilitating its decarboxylation, as shown in Scheme 2. It is not yet clear if the water molecule which facilitates decarboxylation of the active site lysine is the same water molecule that is responsible for hydrolysis of the acyl-enzyme. Perhaps the bulky inhibitor has moved the water molecule from a position where it interacts with the terminus of the carboxylated lysine and the active site serine, to a position where it simultaneously interacts with the protonated carbamic acid and the ε-nitrogen of the lysine, thus facilitating decarboxylation as shown in Scheme 2.

CONCLUSIONS

In summary, the results of these experiments and the underlying mechanistic explanations provide unique insights that lead us further along the path to understanding on a very fundamental level the reaction chemistry and mechanism of inhibition of these clinically important class D OXA carbapenemases. As the pathogen harboring this β-lactamase (A. baumannii) has become a major threat to our antimicrobial armamentarium, new chemical approaches are desperately needed. The importance of the single turnover reaction cannot be overstated. In effect, we demonstrate that under the appropriate conditions, an OXA-24 β-lactamase is “trapped” and becomes catalytically incompetent as a result of a single turnover interaction with an inhibitor. This unprecedented observation has significant ramifications. The challenge here will be to capitalize on this finding and create novel classes of compounds that accelerate decarboxylation and retard the repopulation of Lys84 by carboxylate. This unique strategy creates an entirely new goal in synthetic chemistry that may be approached using both β-lactam scaffolds that preserve our existing drugs as well as by fragment-based libraries.45 In the latter case, diverse chemotypes may be exploited to achieve single turnover kinetics.

Supplementary Material

1_si_001

Box 1. 2′ β-(Phenylacetoxy)-6Z-(α’-pyridylmethylidene) penicillin sulfone, SA-1-204.

Box 1

Acknowledgement

This work was supported by NIH GM54072 to Paul R. Carey and John D. Buynak. Robert A, Bonomo is also supported by the VISN 10 GRECC, a Merit Review Award by the VHA, and NIH RO1-AI072219-05.

Footnotes

Supporting Information Available: SI Figures 1-2 showing detailed Raman difference spectra of the reaction in OXA-24 crystals, kinetic trace of the main Raman peaks. SI Figure 3 showing the effect of bicarbonate on the solution reaction between OXA-24 and SA-1-204. SI Text showing acquisition of Raman difference spectrum and calculation of active site concentration. This information is available free of charge via the Internet at http://pubs.acs.org/.

REFERENCES

  • (1).Poirel L, Naas T, Nordmann P. Antimicrob Agents Chemother. 2010;54:24. doi: 10.1128/AAC.01512-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Bou G, Oliver A, Martinez-Beltran J. Antimicrob Agents Chemother. 2000;44:1556. doi: 10.1128/aac.44.6.1556-1561.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. Antimicrob Agents Chemother. 2005;49:202. doi: 10.1128/AAC.49.1.202-208.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Gordon NC, Wareham DW. Int J Antimicrob Agents. 2010;35:219. doi: 10.1016/j.ijantimicag.2009.10.024. [DOI] [PubMed] [Google Scholar]
  • (5).Zhao WH, Hu ZQ. Crit Rev Microbiol. 2010;36:245. doi: 10.3109/1040841X.2010.481763. [DOI] [PubMed] [Google Scholar]
  • (6).Poirel L, Nordmann P. Clin Microbiol Infect. 2006;12:826. doi: 10.1111/j.1469-0691.2006.01456.x. [DOI] [PubMed] [Google Scholar]
  • (7).Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P. Antimicrob Agents Chemother. 1997;41:2188. doi: 10.1128/aac.41.10.2188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Zavascki AP, Carvalhaes CG, Picao RC, Gales AC. Expert Rev Anti Infect Ther. 2010;8:71. doi: 10.1586/eri.09.108. [DOI] [PubMed] [Google Scholar]
  • (9).Golemi D, Maveyraud L, Vakulenko S, Samama JP, Mobashery S. Proc Natl Acad Sci U S A. 2001;98:14280. doi: 10.1073/pnas.241442898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Cha J, Mobashery S. J Am Chem Soc. 2007;129:3834. doi: 10.1021/ja070472e. [DOI] [PubMed] [Google Scholar]
  • (11).Abendroth J, Niefind K, Schomburg D. J Mol Biol. 2002;320:143. doi: 10.1016/S0022-2836(02)00422-9. [DOI] [PubMed] [Google Scholar]
  • (12).Huang CY, Hsu CC, Chen MC, Yang YS. J Biol Inorg Chem. 2009;14:111. doi: 10.1007/s00775-008-0428-x. [DOI] [PubMed] [Google Scholar]
  • (13).Borbulevych O, Kumarasiri M, Wilson B, Llarrull LI, Lee M, Hesek D, Shi Q, Peng J, Baker BM, Mobashery S. J Biol Chem. 2011;286:31466. doi: 10.1074/jbc.M111.252189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Birck C, Cha JY, Cross J, Schulze-Briese C, Meroueh SO, Schlegel HB, Mobashery S, Samama JP. J Am Chem Soc. 2004;126:13945. doi: 10.1021/ja044742u. [DOI] [PubMed] [Google Scholar]
  • (15).Thumanu K, Cha J, Fisher JF, Perrins R, Mobashery S, Wharton C. Proc Natl Acad Sci U S A. 2006;103:10630. doi: 10.1073/pnas.0601971103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Llarrull LI, Toth M, Champion MM, Mobashery S. J Biol Chem. 2011;286:38148. doi: 10.1074/jbc.M111.288985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Li J, Cross JB, Vreven T, Meroueh SO, Mobashery S, Schlegel HB. Proteins. 2005;61:246. doi: 10.1002/prot.20596. [DOI] [PubMed] [Google Scholar]
  • (18).Ruelle P, Kesselring UW, Ho NT. Theochem-J Mol Struc. 1985;25:41. [Google Scholar]
  • (19).Bou G, Santillana E, Sheri A, Beceiro A, Sampson JM, Kalp M, Bethel CR, Distler AM, Drawz SM, Pagadala SR, van den Akker F, Bonomo RA, Romero A, Buynak JD. J Am Chem Soc. 2010;132:13320. doi: 10.1021/ja104092z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Kumarasiri M, Llarrull LI, Borbulevych O, Fishovitz J, Lastochkin E, Baker BM, Mobashery S. J Biol Chem. 2012;287:8232. doi: 10.1074/jbc.M111.333179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Wilke MS, Hills TL, Zhang HZ, Chambers HF, Strynadka NC. J Biol Chem. 2004;279:47278. doi: 10.1074/jbc.M407054200. [DOI] [PubMed] [Google Scholar]
  • (22).Kalp M, Sheri A, Buynak JD, Bethel CR, Bonomo RA, Carey PR. J Biol Chem. 2007;282:21588. doi: 10.1074/jbc.C700080200. [DOI] [PubMed] [Google Scholar]
  • (23).Buynak JD, Rao AS, Doppalapudi VR, Adam G, Petersen PJ, Nidamarthy SD. Bioorg Med Chem Lett. 1999;9:1997. doi: 10.1016/s0960-894x(99)00325-x. [DOI] [PubMed] [Google Scholar]
  • (24).Altose MD, Zheng Y, Dong J, Palfey BA, Carey PR. Proc Natl Acad Sci U S A. 2001;98:3006. doi: 10.1073/pnas.061029598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Dong J, Swift K, Matayoshi E, Nienaber VL, Weitzberg M, Rockway T, Carey PR. Biochemistry. 2001;40:9751. doi: 10.1021/bi010955+. [DOI] [PubMed] [Google Scholar]
  • (26).Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Jr., Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03; revision C.02. Gaussian, Inc.; Wallingford, CT: 2004. [Google Scholar]
  • (27).Shannon K, Phillips I. J Antimicrob Chemother. 1980;6:617. doi: 10.1093/jac/6.5.617. [DOI] [PubMed] [Google Scholar]
  • (28).Mei LH, Lin DQ, Zhu ZQ, Han ZX. J Chem Eng Data. 1995;40:1168. [Google Scholar]
  • (29).Bulychev A, Mobashery S. Antimicrob Agents Chemother. 1999;43:1743. doi: 10.1128/aac.43.7.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (30).Helfand MS, Totir MA, Carey MP, Hujer AM, Bonomo RA, Carey PR. Biochemistry. 2003;42:13386. doi: 10.1021/bi035716w. [DOI] [PubMed] [Google Scholar]
  • (31).Carey PR. Biochemical Applications of Raman and Resonance Raman Spectroscopies. Academic Press; New York: 1982. [Google Scholar]
  • (32).Chen Y, Basu R, Gleghorn ML, Murakami KS, Carey PR. J Am Chem Soc. 2011;133:12544. doi: 10.1021/ja201557w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Frushour BG, Koenig JL. Biopolymers. 1974;13:1809. doi: 10.1002/bip.1974.360130913. [DOI] [PubMed] [Google Scholar]
  • (34).Pezolet M, Pigeon M, Menard D, Caille JP. Biophys J. 1988;53:319. doi: 10.1016/S0006-3495(88)83109-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (35).Kalp M, Totir MA, Buynak JD, Carey PR. J Am Chem Soc. 2009;131:2338. doi: 10.1021/ja808311s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (36).Santillana E, Beceiro A, Bou G, Romero A. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:5354. doi: 10.1073/pnas.0607557104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (37).Vercheval L, Bauvois C, di Paolo A, Borel F, Ferrer JL, Sauvage E, Matagne A, Frere JM, Charlier P, Galleni M, Kerff F. Biochem J. 2010;432:495. doi: 10.1042/BJ20101122. [DOI] [PubMed] [Google Scholar]
  • (38).Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L, Tafi A, Nordmann P, Botta M, Rossolini GM, Mangani S. Chem Biol. 2009;16:540. doi: 10.1016/j.chembiol.2009.04.010. [DOI] [PubMed] [Google Scholar]
  • (39).Paetzel M, Danel F, de Castro L, Mosimann SC, Page MG, Strynadka NC. Nat Struct Biol. 2000;7:918. doi: 10.1038/79688. [DOI] [PubMed] [Google Scholar]
  • (40).Sun T, Nukaga M, Mayama K, Braswell EH, Knox JR. Protein Sci. 2003;12:82. doi: 10.1110/ps.0224303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (41).Carey PR. Annu Rev Phys Chem. 2006;57:527. doi: 10.1146/annurev.physchem.57.032905.104521. [DOI] [PubMed] [Google Scholar]
  • (42).Maveyraud L, Golemi D, Kotra LP, Tranier S, Vakulenko S, Mobashery S, Samama JP. Structure. 2000;8:1289. doi: 10.1016/s0969-2126(00)00534-7. [DOI] [PubMed] [Google Scholar]
  • (43).Santillana E, Beceiro A, Bou G, Romero A. Proc Natl Acad Sci U S A. 2007;104:5354. doi: 10.1073/pnas.0607557104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (44).Tien M, Berlett BS, Levine RL, Chock PB, Stadtman ER. Proc Natl Acad Sci U S A. 1999;96:7809. doi: 10.1073/pnas.96.14.7809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (45).Teotico DG, Babaoglu K, Rocklin GJ, Ferreira RS, Giannetti AM, Shoichet BK. Proc Natl Acad Sci U S A. 2009;106:7455. doi: 10.1073/pnas.0813029106. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES